EUROPEAN CANCER PATIENT COALITION -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 30
As coordinator: 0
As participant: 30
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 1.972.261 22.125 1
2022 0 56.689.193 1.195.845 10
2021 0 36.523.122 788.125 4
2020 0 16.194.901 395.104 2
2019 0 31.888.742 552.812 5
2018 0 9.727.723 79.994 2
2017 0 19.404.068 225.957 4
2016 0 11.782.965 246.250 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM8
TTOPSTART BV7
JANSSEN PHARMACEUTICA NV5
KATHOLIEKE UNIVERSITEIT LEUVEN5
STICHTING VUMC5
BAYER4
EUROPEAN ASSOCIATION FOR PALLIATIVE CARE4
F HOFFMANNLA ROCHE4
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON4
PFIZER LIMITED4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
UNIVERSITEIT MAASTRICHT4
ACADEMISCH ZIEKENHUIS GRONINGEN3
ASTELLAS PHARMA EUROPE BV3
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD3
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
HOSPICE CASA SPERANTEI3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
KAROLINSKA INSTITUTE3
KING'S COLLEGE LONDON3
NOVARTIS PHARMA3
STICHTING KATHOLIEKE UNIVERSITEIT3
TECHNISCHE UNIVERSITAET MUENCHEN3
THE UNIVERSITY OF MANCHESTER3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA VITASALUTE SAN RAFFAELE3
UNIVERSITY COLLEGE LONDON3
VRIJE UNIVERSITEIT BRUSSEL3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
AMGEN2
ASSOCIATION EISBM2
AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
CELGENE MANAGEMENT SARL2
CENTRE DE REGULACIO GENOMICA2
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
DRESDEN UNIVERSITY OF TECHNOLOGY2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ELI LILLY AND COMPANY LIMITED2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
ERASMUS UNIVERSITEIT ROTTERDAM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN ASSOCIATION OF PALLIATIVE CARE2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FUNDACIO INSTITUT DE RECERCA BIOMEDICA2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA2
HEALTH INNOVATION VENTURES BV2
HELMHOLTZZENTRUM DRESDENROSSENDORF EV2
HOSPICES CIVILS DE LYON2
HOSPITAL CLINIC DE BARCELONA2
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
ISTITUTO EUROPEO DI ONCOLOGIA2
JOHANNES GUTENBERG UNIVERSITAET MAINZ2
LUND UNIVERSITY2
LYON INGENIERIE PROJETS2
MEDIZINISCHE UNIVERSITAT GRAZ2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
ONCORADIOMICS2
PECSI TUDOMANYEGYETEM UNIVERSITY OF PECS2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
SEMMELWEIS UNIVERSITY OF MEDICINE2
SIHTASUTUS POHJAEESTI REGIONAALHAIGLA2
STICHTING EUROPEAN UROLOGICAL FOUNDATION2
STICHTING LYGATURE2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
TARTU ULIKOOL2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE GENERAL HOSPITAL CORPORATION2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF LIVERPOOL2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITAETSKLINIKUM HEIDELBERG2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITATSKLINIKUM BONN2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF CAMBRIDGE2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF LANCASTER2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF OSLO2
UPPSALA UNIVERSITET2
AALBORG UNIVERSITET1
ABBVIE1
ABBVIE INC1
ACADEMISCH ZIEKENHUIS MAASTRICHT1
ACCELOPMENT SCHWEIZ1
ACTELION PHARMACEUTICALS1
AINIGMA TECHNOLOGIES1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1

Constancy:

Total number of partners: 544
Partner loyalty:
Frequent Partner: (> 2 projects): 109
Rare Partner: 435
Frequent / Rare Partner Ratio: 0.25

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Expanding Digital Health through a pan-European EHRxF-based Ecosystem XpanDHparticipant1.972.26126
2022-11-01PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors PREFERABLE-IIparticipant5.925.46314
2022-11-01Data-driven cancer genome interpretation for personalised cancer treatment CGI-Clinicsparticipant9.257.50817
2022-09-01PALliative Care Yields Cancer welLbEing Support PAL-CYCLESparticipant4.473.95810
2022-09-01INtegrated Short-term PallIative REhabilitation to improve quality of life and equitable care access in incurable cancer INSPIREparticipant2.442.80711
2022-09-01A European-wide foundation to accelerate Data-driven Cancer Research EOSC4Cancerparticipant7.814.54934
2022-09-01Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment. OncoProToolsparticipant2.331.26620
2022-09-01Developing and implementing innovative Patient-Centred Care Pathways for cancer patients MyPathparticipant4.773.47015
2022-09-01AI powered Data Curation & Publishing Virtual Assistant AIDAVAparticipant7.720.61514
2022-09-01Improving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal intervention, combining pain and cachexia management, nutrition, and physical activity RELEVIUMparticipant5.997.31218
2022-06-01Pain relief in palliative care of cancer using home-based neuromodulation and predictive biomarkers PAINLESSparticipant5.952.24519
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99739
2021-02-01Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine TIGERparticipant6.900.0008
2021-01-01International consortium for integrative genomics prediction INTERVENEparticipant10.434.94018
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-01-01Integrated and standardized NGS workflows for Personalised therapy Instand-NGS4Pparticipant10.998.12822
2020-01-01Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management QUALITOPparticipant5.196.77316
2019-12-01A Collective Intelligence Platform to Support Cancer Champions LifeChampsparticipant4.999.91516
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-01-01CeLac and European consortium for a personalized medicine approach to Gastric Cancer LEGACyparticipant3.577.43111
2019-01-01Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial DIAdICparticipant4.277.87511
2019-01-01The use of proportional palliative sedation for the relief of refractory symptoms: an international multicenter study PalliativeSedationparticipant4.033.52010
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00034
2018-01-01European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools ELBAparticipant3.727.72321
2017-12-01A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer IMMUNISAparticipant6.000.0006
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer IMMUNOSABRparticipant5.994.17617
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-01-01DC-based immunotherapy to treat Malignant Mesothelioma H2020MM04participant5.782.9658